0001209191-19-036585.txt : 20190613 0001209191-19-036585.hdr.sgml : 20190613 20190613061151 ACCESSION NUMBER: 0001209191-19-036585 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190611 FILED AS OF DATE: 20190613 DATE AS OF CHANGE: 20190613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIEBERMAN GERALD M CENTRAL INDEX KEY: 0001234346 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 19894857 MAIL ADDRESS: STREET 1: C/O ALLIANCE CAPITAL STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-11 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001234346 LIEBERMAN GERALD M C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 1 0 0 0 Restricted Share Units 2019-06-11 4 A 0 17621 0.00 A Ordinary Shares 17621 17621 D Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on June 11, 2019 and vest on June 11, 2020. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. /s/ Dov Bergwerk as attorney-in-fact for Gerald M. Lieberman 2019-06-13